Xbrane Biopharma AB (publ) announced that the Nomination Committee for the AGM in 2022 has been set up to consist of the following persons, which together represent approximately 30% of the number of shares and votes in the Company as of September 30, 2021: Saeid Esmaeilzadeh appointed by Serendipity Group AB, the Company?s largest shareholder, Ulrik Gr?nvall appointed by Swedbank Robur Fonder, the Company?s second largest shareholder, Bengt G?ran Westman, the Company?s third largest shareholder. Saeid Esmaeilzadeh has been appointed as chairman of the Nomination Committee.